Bloodwork is the only objective way to confirm what is happening at the biomarker level. Subjective markers — energy, mood, recovery — are valuable for tracking trends, but they cannot tell you your hematocrit, your hormone levels, or whether metabolic markers are moving in the expected direction. For anyone running a compound protocol, periodic blood panels are the gold standard for data.
The question is not whether to get bloodwork. It is when — and the answer depends on what you are running and what you are trying to learn.
The Bloodwork Timeline
Most protocols follow a three-phase bloodwork schedule. The specific timing varies by compound, but the structure is consistent.
Baseline — Before Starting
Get a comprehensive panel before administering your first dose. This is your reference point. Without baseline numbers, you cannot distinguish compound effects from pre-existing levels. A common baseline panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, and any compound-specific markers.
First Recheck — 4 to 6 Weeks
By week 4 to 6, most compounds have reached or are approaching steady state. This is the point where blood levels reflect what your protocol is actually producing, rather than the transient ramp-up phase. Comparing this draw to baseline reveals the compound's impact on your markers.
Periodic Monitoring — Every 8 to 12 Weeks
For ongoing protocols, periodic rechecks every 2 to 3 months allow you to track trends over time. This catches gradual shifts that a single comparison might miss — markers that are slowly moving in a direction you want to be aware of.
Which Panels for Which Compounds
Different compound categories affect different biomarkers. Running the right panel means getting actionable data without paying for irrelevant tests.
Testosterone & Hormone Protocols
Hormone protocols have the most established bloodwork framework. The key markers provide a comprehensive picture of how exogenous testosterone is affecting the endocrine system and downstream health markers.
GLP-1 Receptor Agonists
GLP-1 compounds primarily affect metabolic markers. The panels commonly monitored reflect the metabolic pathways these compounds are known to influence.
General Peptides (BPC-157, TB-500, GHK-Cu, etc.)
Most healing and cosmetic peptides do not have established bloodwork panels in the same way hormones do. They do not typically appear on standard blood tests. However, monitoring general health markers while running any compound is prudent practice.
GH Secretagogues (CJC-1295, Ipamorelin, etc.)
If monitoring growth hormone axis response, specific markers can indicate whether the secretagogue is producing the expected pituitary output.
Why Trough Timing Matters for Hormones
For hormone protocols — particularly testosterone — the time of your blood draw relative to your last dose significantly affects the results. A draw 24 hours after injection will show near-peak levels. A draw immediately before your next injection shows trough levels. These two numbers from the same person on the same protocol can differ by 50% or more.
The convention in the TRT and hormone community is to draw at trough — immediately before your next scheduled dose. This gives the most conservative and reproducible measurement, and it is the number that is most comparable across time periods. If you always draw at trough, you can meaningfully compare your week-6 trough to your week-12 trough.
If you draw at random times relative to your dose, the numbers become difficult to interpret. A higher reading might mean your levels have increased, or it might just mean you drew closer to your last injection. Consistency in draw timing eliminates this variable.
If you inject testosterone twice per week (e.g., Monday and Thursday), schedule your blood draw for Thursday morning before your Thursday injection. This gives you a true trough reading. Knowing your saturation level on draw day helps contextualize the results — you can see exactly where in the concentration curve you were at the time of the draw.
Fasting Requirements
Most panels produce more reliable results when drawn fasted (8 to 12 hours without food). This is particularly important for:
- Glucose and insulin: Food intake directly affects these within hours.
- Lipids: Triglycerides especially are affected by recent meals.
- Metabolic panels: Fasting provides cleaner baseline numbers.
Hormones like testosterone and estradiol are less affected by food, but drawing fasted keeps the conditions consistent across all panels and timepoints.
Where to Get Bloodwork
Options vary by country, but the general categories are:
- Direct-to-consumer labs — Services that allow you to order panels without a doctor's order and walk into a lab for a draw. Common in the US and increasingly available in Australia and the UK.
- GP / Primary care — Your doctor can order panels, though they may not order compound-specific markers without context.
- Telehealth clinics — Many TRT and peptide clinics include periodic bloodwork in their service. These clinics are generally familiar with the relevant markers.
Regardless of the source, what matters is that the results include reference ranges and that you keep copies of all results for personal comparison over time.
Reading Your Results
Two principles for interpreting bloodwork on any protocol:
- Trends matter more than single readings. One high or low value is a data point. A consistent pattern across 2 to 3 draws is a trend. Focus on direction rather than absolute numbers.
- Compare to your own baseline, not just the reference range. Reference ranges represent population averages. Your pre-protocol baseline is a much more relevant comparison point because it accounts for your individual physiology.
Logging bloodwork results alongside your protocol data — dose history, saturation levels, subjective check-ins — creates a complete picture that none of those data streams provide alone.